Periodical (Journal)

ISSN  :   2730-6011 ( Online )   Active

Journal Discover Oncology

Aim & Scope

Discover Oncology is part of the Discover journal series committed to providing a streamlined submission process, rapid review and publication, and a high level of author service at every stage. Discover Oncology is a fully open access general oncology journal that aims to provide a unified forum for researchers and clinicians. The journal spans from basic and translational science, through to preclinical, clinical, and epidemiology, and welcomes content that interfaces at all levels of cancer research. Topics: Discover Oncology covers topics including, but not limited to, cancer causation and the underlying biology of disease, the molecular interactions between genes, hormones, the immune system and the metabolism, screening and prevention, diagnosis and treatment, prognostication, novel therapeutic agents and clinical trials. All cancer types, including benign tumors, will be considered for publication. [1]

Go to Website

Continuations / Journal History
(  2010  -  2020  ) Hormones and Cancer (  2021  -  9999  ) Discover Oncology
Series / Collection
42 RESULTS in 6 msec
Active ( 2023  -  9999 )   Discover Agriculture

2731-9598 ( Online ) 
Springer

2 46
Active ( 2023  -  9999 )   Discover Analytics

2731-8117 ( Online ) 
Springer

2 15
Active ( 2024  -  9999 )   Discover Animals

3004-894X ( Online ) 
Springer

1 10
Active ( 2024  -  9999 )   Discover Applied Sciences

3004-9261 ( Online ) 
Springer

8 383
Active ( 2021  -  9999 )   Discover Artificial Intelligence

2731-0809 ( Online ) 
Springer

4 137
Active ( 2023  -  9999 )   Discover Atmosphere

2948-1554 ( Online ) 
Springer

2 5
Active ( 2024  -  9999 )   Discover Bacteria

3004-9768 ( Online ) 
Springer

1 1
Active ( 2021  -  9999 )   Discover Chemical Engineering

2730-7700 ( Online ) 
Springer

4 55
Active ( 2024  -  9999 )   Discover Chemistry

3005-1193 ( Online ) 
Springer

1 6
Active ( 2024  -  9999 )   Discover Cities

3004-8311 ( Online ) 
Springer

1 11
 

2024 - VOLUME 15, ISSUE 1
287 RESULTS in 28 msec
2024-07-16

AURKB promotes immunogenicity and immune infiltration in clear cell renal cell carcinoma

W Liu , Y Liu , S Chen , ... , S He

Discover Oncology , 2024 - VOLUME 15, ISSUE 1

10.1007/s12672-024-01141-7

0 68

2024-01-02

Associations between HIFs and tumor immune checkpoints: mechanism and therapy.

J Liu , Y Jiang , L Chen , ... , Y Zhang

Discover Oncology , 2024 - VOLUME 15, ISSUE 1 , p 2.

10.1007/s12672-023-00836-7

  Review
0 212

2024-01-08

A novel cholesterol metabolism-related ferroptosis pathway in hepatocellular carcinoma.

W Fang , J Liu , F Zhang , ... , X Li

Discover Oncology , 2024 - VOLUME 15, ISSUE 1 , p 7.

10.1007/s12672-023-00822-z

  0 28

 

Editorial Retractions, Expressions of Concern and External Notices
1 RESULTS in 7 msec
2021-12-01

IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.

K Sasa , T Saito , T Kurihara , ... , Y Suehara

Discover Oncology
2021 - VOLUME 12, ISSUE 1 p 57.
  Retracted Publication
1 19
2022-05-10

Notice of Retraction

K Sasa , T Saito , T Kurihara , ... , Y Suehara

Discover Oncology
2022 - VOLUME 13, ISSUE 1

p 20.
  Retraction of Publication
0 1

2022-03-25

PubPeer Comment

Hoya Camphorifolia

PubPeer
2022 - VOLUME 2022, ISSUE 3

  Website - Forum Post External CQC
0 0